AbbVie Inc. is a research-driven biopharmaceutical company focused on discovering and delivering advanced therapies for complex diseases. The company operates across immunology, oncology, neuroscience, and eye care, combining scientific innovation with global commercialization capabilities to serve patients and healthcare systems worldwide.
AbbVie develops and markets prescription medicines and biologics across multiple therapeutic areas. Its solutions are supported by strong R&D capabilities, clinical development programs, and global manufacturing infrastructure. The company collaborates with healthcare providers to improve disease management and patient outcomes through science-based therapies.
Sustainability at AbbVie centers on patient access, ethical governance, environmental stewardship, and workforce development. The company prioritizes responsible manufacturing, reduced environmental impact, and transparent governance. Its ESG strategy integrates long-term value creation, compliance, and social responsibility across global operations.
AbbVie operates in more than 70 countries with research centers, manufacturing sites, and commercial offices. Its global footprint enables broad patient access to innovative therapies while supporting region-specific healthcare needs through localized operations and partnerships.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| AbbVie Inc. | https://www.abbvie.com/ |
| Company Name | AbbVie Inc. |
| Solutions Offered | Specialty drugs, immunology treatments, oncology therapies |
| Application Areas | Chronic diseases, cancer treatment, immune disorders |
| Industry | Biopharmaceuticals |
| Core Focus | Research and development of innovative medicines |
| Sustainability Recognition | Strong emphasis on patient access, ethics, and ESG initiatives |
| Key Technologies | Biologics, advanced drug discovery, targeted therapies |